Paul E. Freiman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul E. Freiman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul E. Freiman. Paul E. Freiman is Director in NovaBay Pharmaceuticals, Inc. ($NBY) and See Remarks in Neurotrope, Inc. ($NTRP).
Latest Insider Trading Transactions of Paul E. Freiman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2020 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 0.89 | 20,000 | 17,800 | 20,000 | |
| Oct 28 2019 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
| Jun 04 2018 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 62,697 | |
| Jan 04 2017 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 3.24 | 25,916 | 83,968 | 67,097 | |
| Jan 04 2017 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 3.24 | 25,916 | 83,968 | 67,097 | |
| Jan 06 2016 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 2.02 | 26,835 | 54,207 | 41,181 | |
| Nov 20 2015 | NTRP | Neurotrope, Inc. | Freiman Paul E. | See Remarks | Option Exercise | A | 0.80 | 200,000 | 160,000 | 200,000 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | Freiman Paul E. | See Remarks | Option Exercise | P | 1.50 | 166,667 | 250,001 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | Freiman Paul E. | See Remarks | Option Exercise | P | 1.00 | 166,667 | 166,667 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | Freiman Paul E. | See Remarks | Option Exercise | P | 1.25 | 166,667 | 208,334 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | Freiman Paul E. | See Remarks | Option Exercise | P | 0.80 | 166,667 | 133,334 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | Freiman Paul E. | See Remarks | Option Exercise | P | 0.80 | 166,667 | 133,334 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | Freiman Paul E. | See Remarks | Option Exercise | P | 0.00 | 1,667 | 0 | 166,667 | |
| Jan 06 2015 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 0.64 | 121,144 | 77,532 | 358,654 | |
| Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 237,510 | |
| Jan 15 2013 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 222,510 | |
| Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | X | 0.20 | 30,000 | 6,000 | 30,000 | |
| Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Buy | X | 0.20 | 30,000 | 6,000 | 45,137 | 15.1 K to 45.1 K (+198.19 %) |
| Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.33 | 67,510 | 89,788 | 67,510 | |
| Sep 13 2011 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Buy | P | 0.84 | 3,000 | 2,520 | 15,137 | 12.1 K to 15.1 K (+24.72 %) |
| Jan 05 2011 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.67 | 15,000 | 25,050 | 15,000 | |
| Aug 18 2010 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,428 | 0 | 25,444 | 26.9 K to 25.4 K (-5.31 %) |
| Jan 16 2009 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 9,084 | 0 | 42,496 | 33.4 K to 42.5 K (+27.19 %) |
| Aug 26 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,353 | 0 | 33,412 | 32.1 K to 33.4 K (+4.22 %) |
| Jun 09 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 978 | 0 | 32,059 | 31.1 K to 32.1 K (+3.15 %) |
| Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,216 | 0 | 31,081 | 29.9 K to 31.1 K (+4.07 %) |
| Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 263 | 0 | 29,865 | 29.6 K to 29.9 K (+0.89 %) |
| Mar 07 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,015 | 0 | 29,602 | 28.6 K to 29.6 K (+3.55 %) |
| Mar 04 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,173 | 0 | 28,587 | 27.4 K to 28.6 K (+4.28 %) |
| Feb 13 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 205 | 0 | 27,414 | 27.2 K to 27.4 K (+0.75 %) |
| Jan 15 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,162 | 0 | 27,209 | 26 K to 27.2 K (+4.46 %) |
| Dec 17 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 698 | 0 | 26,047 | 25.3 K to 26 K (+2.75 %) |
| Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 119 | 0 | 25,349 | 25.2 K to 25.3 K (+0.47 %) |
| Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 117 | 0 | 25,230 | 25.1 K to 25.2 K (+0.47 %) |
| Nov 07 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 113 | 0 | 25,113 | 25 K to 25.1 K (+0.45 %) |
Page: 1